:: UTM Library Massive Scholar Tracking

<sec><title>Introduction</title><p id="para1">The widespread screening programs prompted a decrease in prostate cancer stage at diagnosis, and active surveillance is an option for patients who may harbor clinically insignificant prostate cancer (IPC). Pathologists i...

Full description

Bibliographic Details
Main Authors:	Betina Katz, Miguel Srougi, Luiz H. Camara-Lopes, Alberto A. Antunes, Luciano Nesrallah, Adriano Nesrallah, Marcos Dall'Oglio, Katia R. M. Leite
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Urologia 2012-12-01
Series:	International Brazilian Journal of Urology
Subjects:	Prostate cancer Prostate Gleason score Diagnosis
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382012000600760

Similar Items

The accuracy of pathological data for the prediction of insignificant prostate cancer
by: Betina Katz, et al.
Published: (2012-12-01)

Histopathological findings in extended prostate biopsy with PSA ≤ 4 ng/mL
by: Katia R. Leite, et al.
Published: (2008-06-01)

Correlação entre a graduação histológica de biópsias e do espécimen cirúrgico em câncer da prostata
by: José Cury, et al.

Survival of patients with prostate cancer and normal PSA levels treated by radical prostatectomy
by: Marcos F. Dall'oglio, et al.
Published: (2005-06-01)

Preoperative determination of prostate cancer tumor volume: analysis through biopsy fragments
by: Alberto A. Antunes, et al.
Published: (2007-08-01)

Socioeconomic status is an independent predictor of biochemical recurrence among patients with prostate cancer who undergo radical prostatectomy
by: Victor Srougi, et al.
Published: (2011-08-01)

Predictive value of PSA velocity over early clinical and pathological parameters in patients with localized prostate cancer who undergo radical retropubic prostatectomy
by: Martinez Carlos A.L., et al.
Published: (2004-01-01)

US Preventive Services Task Force prostate-specific antigen screening guidelines result in higher Gleason score diagnoses
by: Glen Gejerman, et al.
Published: (2017-11-01)

Serum PSA and cure perspective for prostate cancer in males with nonpalpable tumor
by: Marcos F. Dall'Oglio, et al.
Published: (2005-10-01)

Analysis of risk factors of involvement of seminal vesicles in patients with prostate cancer undergoing radical prostatectomy
by: Marcos F. Dall'Oglio, et al.
Published: (2004-12-01)

Histopathological diagnoses and patterns in transrectal ultrasound-guided prostatic biopsy series from a large tertiary care center in Saudi Arabia
by: Ali A Alsulihem, et al.
Published: (2021-01-01)

Microvascular invasion is an independent prognostic factor in patients with prostate cancer treated with radical prostatectomy
by: Alberto A. Antunes, et al.
Published: (2006-12-01)

Gleason score 6: Overdiagnosis and overtreatment?
by: Yaxiong Tang, et al.
Published: (2023-06-01)

Age impact in clinicopathologic presentation and the clinical evolution of prostate cancer in patients submitted to radical prostatectomy
by: Alberto A. Antunes, et al.
Published: (2006-02-01)

A second opinion pathology review improves the diagnostic concordance between prostate cancer biopsy and radical prostatectomy specimens
by: Takanori Maehara, et al.
Published: (2021-01-01)

Quantification of tumor extension in prostate biopsies: importance in the identification of confined tumors
by: Leite Kátia R.M., et al.
Published: (2003-01-01)

Correlation and diagnostic performance of the prostate-specific antigen level with the diagnosis, aggressiveness, and bone metastasis of prostate cancer in clinical practice
by: Bannakij Lojanapiwat
Published: (2014-09-01)

Misanian Men, are or aren't a Prostatic Adenocarcinoma?
by: Haider Qasim Alhelfi
Published: (2021-04-01)

Prostate biopsy: is age important for determining the pathological features in prostate cancer?
by: Alberto A. Antunes, et al.
Published: (2005-08-01)

Pathological extension of prostate cancer as defined by gleason score on biopsy
by: Marcos F. Dall'oglio, et al.
Published: (2005-08-01)

Second to fourth digit ratio: its relationship with core cancer volume and Gleason score in prostate biopsy
by: Jin Kyu Oh, et al.
Published: (2012-10-01)

The use of immunohistochemistry for diagnosis of prostate cancer
by: Katia R. M. Leite, et al.
Published: (2010-10-01)

Prostate cancer detection at rebiopsy after an initial benign diagnosis: results using sextant extended prostate biopsy
by: Katia Ramos Moreira Leite, et al.
Published: (2008-01-01)

Collagen I and III and metalloproteinase gene and protein expression in prostate cancer in relation to Gleason score
by: Antonio H. Duarte, et al.
Published: (2012-06-01)

MRI-derived Restriction Spectrum Imaging Cellularity Index is Associated with High Grade Prostate Cancer on Radical Prostatectomy Specimens
by: Michael Andre Liss, et al.
Published: (2015-02-01)

The effect of the discrepancy between pre- and post-operative staging on decision-making and quality of life in men undergoing a radical prostatectomy
by: Álvaro Martínez-Bordajandi, et al.
Published: (2023-07-01)

Multimodal Radiomic Features for the Predicting Gleason Score of Prostate Cancer
by: Ahmad Chaddad, et al.
Published: (2018-07-01)

Extraprostatic extension of gleason 6 prostate cancer: single center experience
by: Onur Ceylan, et al.
Published: (2021-06-01)

Prostate cancer: Relationship between vascular diameter, shape and density and Gleason score in needle biopsy specimens
by: Farhad Tadayyon, et al.
Published: (2013-01-01)

Biochemical recurrence rates are similar for pT2-positive surgical margins and pT3a
by: Katia R. M. Leite, et al.
Published: (2014-04-01)

Value of various PSA parameters for diagnosing prostate cancer in men with normal digital rectal examination
by: Ari Miotto Jr, et al.
Published: (2004-04-01)

Evaluation of the pathologic results of prostate biopsies in terms of age, Gleason score and PSA level: Our experience and review of the literature
by: Selcuk Sarıkaya, et al.
Published: (2014-12-01)

miR-21 may acts as an oncomir by targeting RECK, a matrix metalloproteinase regulator, in prostate cancer
by: Reis Sabrina, et al.
Published: (2012-05-01)

The relationship between methylation of tumor suppressor genes <i>APC</i>, <i>GSTP1</i>, <i>RASSF1A</i> and content of prostate-specific antigen- associated markers in prostate cancer diagnosis
by: I. A. Aboyan, et al.
Published: (2023-10-01)

Perineural invasion, Gleason score and prostate specific antigen; is there any association?
by: Mohammad Yazdani, et al.
Published: (2019-10-01)

A high high-density lipoprotein level is associated with Gleason score upgrade in Chinese patients diagnosed with high-grade prostate carcinoma
by: Jingcheng Lyu, et al.
Published: (2023-01-01)

When to perform bone scintigraphy in patients with newly diagnosed prostate cancer? a retrospective study
by: Yiwei Lin, et al.
Published: (2017-06-01)

Localization of higher grade tumor foci in potential candidates for active surveillance who opt for radical prostatectomy
by: Sung Kyu Hong, et al.
Published: (2013-12-01)

Gleason 6 prostate cancer: That which cannot be named
by: Harry B. Burke
Published: (2022-12-01)

Expression of GP88 (progranulin) in serum of prostate cancer patients is associated with Gleason scores and overall survival
by: Greither T, et al.
Published: (2018-10-01)